Digirad Corporation Reports Second Quarter 2009 Financial Results

Friday, September 18, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

POWAY, Calif., July 23 Digirad Corporation (Nasdaq: DRAD), today reported that stronger revenue from its Product (nuclear camera) business combined with company-wide efficiency measures resulted in improved gross margins, $784,000 in net profits and more than $3 million in positive cash flow in its second quarter ended June 30, 2009.

Digirad CEO Todd Clyde said, "We saw strong performance by our DIS personnel and equipment leasing business and a rebound in our camera business in the second quarter. Selling more cameras, increasing utilization, and driving other operational and overhead efficiencies allowed us to generate profit from operations, positive cash flow and a second consecutive quarter of net income." Clyde continued, "Our cash position increased to more than $31 million, a solid achievement that highlights our 2009 focus and commitment to create a consistently profitable, cash generating company."

Second Quarter Financial Highlights:

Year-to-Date Financial Highlights:

"Our results continue to show significant progress and our focus remains on profitability and cash generation. We have now sold or closed all underperforming hubs, continue to refine our Centers of Influence model, and are amid introductions of new imaging technologies." Clyde continued, "Near-term impacts of summer seasonality along with more global market issues such as hospital budgets, reimbursement, and the economy will continue to challenge our markets and us, but we are hitting our milestones as planned and intend to continue that trend. We are experiencing a positive response to our new Cardius((R)) X-ACT imaging system in the hospital and larger cardiology practice market segments. We believe we will continue to take the steps necessary to navigate through these times and we are optimistic about our future."

Conference Call Information

A conference call is scheduled for 11:00 a.m. EDT today to discuss the results and management's outlook. The call may be accessed by dialing 866-226-4514 five minutes prior to the scheduled start time and referencing Digirad. A simultaneous webcast of the call may be accessed online from the Events & Presentations link on the Investor Relations page at www.digirad.com; an archived replay of the webcast will be available within 15 minutes of the end of the conference call.

About Digirad Corporation

Digirad is a leading provider of diagnostic imaging products, and personnel and equipment leasing services. For more information, please visit www.digirad.com. Digirad((R)), Digirad Imaging Solutions((R)), and Cardius((R)) are registered trademarks of Digirad Corporation.

Forward-Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the efficacy of Digirad's centers of influence model, the status of the negotiation of the sale or closure of underperforming hub locations, and the ability to achieve positive cash flow and profitability, drive technology progress and improve services utilization to grow market share. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks associated with changes in business conditions, technology, customers' business conditions, reimbursement, radiopharmaceutical shortages, economic outlook, operational policy or structure, acceptance and use of Digirad's camera systems and services, reliability, recalls, and other risks detailed in Digirad's filings with the U.S. Securities and Exchange Commission, including Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports. Readers are cautioned to not place undue reliance on these forward looking statements, which speak only as of the date hereof. All forward looking statements are qualified in their entirety by this cautionary statement, and Digirad undertakes no obligation to revise or update the forward looking statements contained herein.

-- Total revenue was $18.6 million, compared to $19.9 million in the second-quarter of 2008, mainly due to the sale of certain DIS hubs earlier this year and fewer nuclear camera sales. DIS revenue declined slightly to $13.6 million compared to $14.2 million in the second-quarter of 2008 and Product revenues declined slightly to $5.0 million compared to $5.7 million in the second-quarter 2008, but increased from $3.9 million in the 2009 first quarter. -- Gross profit increased to $5.9 million, or 32% of revenue, compared to $4.6 million, or 23%, in second-quarter of 2008. -- Net income was $0.8 million, or $0.04 per share, compared to net loss of $1.2 million, or $(0.06) per share, in second-quarter of 2008. -- Cash and cash equivalents and securities available-for-sale totaled $31.5 million, or $1.66 per share, at June 30, 2009. Cash and cash equivalents and securities available-for-sale were $24.6 million at June 30, 2008 and $28.3 million at December 31, 2008. -- DIS asset utilization was 63% on 155 systems (nuclear and ultrasound), compared to 57% on 164 systems (nuclear and ultrasound) during second-quarter of 2008.

SOURCE Digirad Corporation

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store